학술논문

REMODEL I/II Trials: Efficacy, Safety, and Tolerability of Remibrutinib in Patients With Relapsing Multiple Sclerosis
Document Type
Journal
Source
EUROPEAN JOURNAL OF NEUROLOGY; JUL 2022, 29 p219-p220, 2p. Supplement: 1
Subject
Language
English
ISSN
14681331